Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Meeting Abstract

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z. X.; Tallman, M. S.; Patel, J. P.; Gonen, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The impact of clonal architecture of IDH1 and IDH2 mutant cases on the biology of myeloid malignancies
    Meeting Abstract

    Thota, S.; Makishima, H.; Przychodzen, B. P.; Viny, A. D.; Patel, B. J.; Radivoyevitch, T.; Sekeres, M. A.; Carraway, H. E.; Haferlach, T.; Ogawa, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Long-term follow-up of a phase 1 study of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML)
    Meeting Abstract

    Talpaz, M.; Cortes, J. E.; Kantarjian, H.; Shah, N. P.; Bixby, D.; Flinn, I.; O'Hare, T.; Hu, S. M.; Rivera, V. M.; Clackson, T.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): Early results of US intergroup trial C10403
    Meeting Abstract

    Stock, W.; Luger, S. M.; Advani, A. S.; Geyer, S.; Harvey, R. C.; Mullighan, C. G.; Willman, C. L.; Malnassy, G.; Parker, E.; Laumann, K. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim analysis of a phase 1 trial of SGN-CD33A in patients with CD33-positive acute myeloid leukemia (AML)
    Meeting Abstract

    Stein, E. M.; Stein, A.; Walter, R. B.; Fathi, A. T.; Lancet, J. E.; Kovacsovics, T. J.; Advani, A. S.; DeAngelo, D. J.; O'Meara, M. M.; Zhao, B. T.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The DOT1L inhibitor EPZ-5676: Safety and activity in relapsed/refractory patients with MLL-rearranged leukemia
    Meeting Abstract

    Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Savona, M.; Tibes, R.; Altman, J. K.; Jongen-Lavrencic, M.; DoĢˆhner, H.; Armstrong, S.; Pollock, R. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; Patel, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation
    Meeting Abstract

    Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease
    Meeting Abstract

    Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, a small molecule mutant IDH2 inhibitor, remodels the epigenetic state of IDH2-mutant cells and induces alterations in self-renewal/differentiation in IDH2-mutant AML model in vivo
    Meeting Abstract

    Shih, A. H.; Shank, K. R.; Meydan, C.; Intlekofer, A. M.; Ward, P.; Thompson, C. B.; Melnick, A. M.; Travins, J.; Straley, K.; Gliser, C.; more...
    Blood (2014)

    Fulltext@MSK | Save